ipamorelin cancer risk studies Reducing The risk of second primary
Description
Y.GoH.KoS

19805 kez okundu 12 Kasm 2024 Sal Kolajen Nedir

Giacco, F., & Brownlee, M

10.1186/S12864-017-3942-9/FIGURES/3 20 CoutantD
Holl, D

Y.GoH.KoS

19805 kez okundu 12 Kasm 2024 Sal Kolajen Nedir

Giacco, F., & Brownlee, M

10.1186/S12864-017-3942-9/FIGURES/3 20 CoutantD
Holl, D
